Acrivon Therapeutics, Inc.

Develops precision cancer therapies by matching patients to drugs using its proteomics platform.

ACRV | NDAQ

Overview

Corporate Details

ISIN(s):: US0048901096
LEI:
Country:: United States of America
Address:: 480 ARSENAL WAY, SUITE 100, 2472 WATERTOWN
Website:: https://acrivon.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Acrivon Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in precision oncology. The company leverages its proprietary Acrivon Predictive Precision Proteomics (AP3) platform to develop targeted cancer therapies. The AP3 platform utilizes phosphoproteomics to analyze the biologic drivers of a patient's cancer, enabling the creation of predictive 'OncoSignature' tests. This method is designed to match drug candidates with patients whose tumors are most likely to respond, aiming to improve therapeutic outcomes beyond what is achievable with genomics. Acrivon's pipeline is led by ACR-368, a selective kinase inhibitor in Phase 2 clinical trials for various solid tumors. The company also advances its internally developed programs and seeks strategic partnerships to apply its AP3 platform to co-develop predictive tests for external drug candidates.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Acrivon Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Acrivon Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Acrivon Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
CreoSG Co.,Ltd. Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.	South Korea	040350
CRG HOLDINGS CO.,LTD. Provides IT-driven HR services, outsourcing, system solutions, and financial advisory.	Japan	7041
CRONEX.CO.,LTD CRO supplying mini-pigs and bio-tissues for non-clinical R&D in medical and cosmetic industries.	South Korea	215570
Cross Marketing Group Inc. Delivers marketing insights via research and digital solutions using a large Japanese consumer panel.	Japan	3675
CrowdWorks Inc. Japan's largest crowdsourcing service with HR solutions and SaaS to connect companies and talent.	Japan	3900
C&R Research Inc. Leading South Korean CRO offering end-to-end clinical trial services for life science companies.	South Korea	359090
CRYO CELL INTERNATIONAL INC Cryopreserves newborn cord blood and tissue stem cells for expectant families.	United States of America	CCEL
Curasight A/S Developing uPAR theranostics to precisely diagnose and treat cancers like brain and prostate.	Denmark	CURAS
Cyclezyme AB Develops enzymatic solutions for recycling plastic waste into new raw materials.	Sweden	CYCLE
Dark Star Minerals Inc. Exploring for uranium & REEs, critical minerals for the clean energy and tech sectors.	Canada	BATT